Skip to main content
Livermore
Livermore
ZHEN

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

The latest 13F from Ingalls & Snyder LLC covers Q2 2026 (filed Aug 14, 2026): 467 long positions worth $3.66B. The top 10 holdings make up 45.6% of the portfolio, and the largest is Corcept Therapeutics Inc (CORT) at 18.8%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
31
Est. +$277.4M
Added
98
Est. +$150.5M
Reduced
203
Est. −$60.7M
Sold out
21
Est. −$9.97M

Top 5 holdings

Share of this quarter's portfolio value

  1. CORTCorcept Therapeutics Inc
    18.8%$689.9MHistory
  2. OGCOceanaGold Corp
    6.9%$251.9MHistory
  3. GOOGLAlphabet Inc.
    2.9%$106.5MHistory
  4. WMBWilliams Companies, Inc.
    2.8%$101.6MHistory
  5. AAPLApple Inc.
    2.7%$98.1MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. OGCOceanaGold Corp
    +$251.9MNewHistory
  2. FTAIFTAI Aviation Ltd.
    +$45.3MAddedHistory
  3. CORTCorcept Therapeutics Inc
    +$28.3MAddedHistory
  4. NFLXNetflix Inc
    +$12.1MAddedHistory
  5. VanEck ETF Trust92189F791
    +$9.82MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. CORTCorcept Therapeutics Inc
    +7.96 pp10.9% → 18.8%History
  2. OGCOceanaGold Corp
    +6.88 pp0.0% → 6.9%History
  3. FTAIFTAI Aviation Ltd.
    +1.23 pp<0.1% → 1.3%History
  4. VanEck ETF Trust92189F791
    +0.26 pp<0.1% → 0.3%
  5. CCJCameco Corp
    +0.21 pp<0.1% → 0.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. SPYSPDR S&P 500 ETF Trust
    −$7.60MReducedHistory
  2. TMUST-Mobile US, Inc.
    −$7.11MReducedHistory
  3. GSGoldman Sachs Group Inc
    −$4.58MReducedHistory
  4. CNQCanadian Natural Resources Ltd
    −$3.82MReducedHistory
  5. HUNHuntsman CORP
    −$2.82MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CNQCanadian Natural Resources Ltd
    −1.63 pp4.0% → 2.4%History
  2. XOMExxonMobil Holdings Corp
    −1.58 pp4.1% → 2.5%History
  3. PAASPan American Silver Corp
    −1.29 pp3.5% → 2.2%History
  4. WMBWilliams Companies, Inc.
    −0.82 pp3.6% → 2.8%History
  5. TMUST-Mobile US, Inc.
    −0.60 pp1.1% → 0.5%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$3.66B
+$843.2M (+29.9%) vs. prior quarter
Positions
467
+10 vs. prior quarter
Top 10 concentration
45.6%
Top 10 as share of value
Turnover
2.2%
Q2 2026, one quarter
Average holding period
18.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.66B (Q2 2026)

Q1 2021: $2.12BQ2 2021: $2.23BQ3 2021: $2.16BQ4 2021: $2.19BQ1 2022: $2.22BQ2 2022: $1.90BQ3 2022: $1.78BQ4 2022: $1.83BQ1 2023: $1.94BQ2 2023: $2.07BQ3 2023: $2.07BQ4 2023: $2.20BQ1 2024: $2.25BQ2 2024: $2.31BQ3 2024: $2.55BQ4 2024: $2.54BQ1 2025: $3.03BQ2 2025: $2.81BQ3 2025: $3.05BQ4 2025: $2.71BQ1 2026: $2.82BQ2 2026: $3.66B
Q1 2021Q2 2026
13F filings of Ingalls & Snyder LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026467$3.66BCORTOGCGOOGLvs. Q1 2026SEC
Q1 2026May 13, 2026457$2.82BCORTXOMCNQvs. Q4 2025SEC
Q4 2025Feb 13, 2026448$2.71BCORTGOOGLAAPLvs. Q3 2025SEC
Q3 2025Nov 7, 2025454$3.05BCORTMSFTAAPLvs. Q2 2025SEC
Q2 2025Jul 31, 2025445$2.81BCORTMSFTWMBvs. Q1 2025SEC
Q1 2025May 12, 2025435$3.03BCORTBRK.BXOMvs. Q4 2024SEC
Q4 2024Jan 29, 2025428$2.54BCORTAAPLMSFTvs. Q3 2024SEC
Q3 2024Nov 14, 2024439$2.55BCORTXOMAAPLvs. Q2 2024SEC
Q2 2024Jul 31, 2024414$2.31BCORTXOMMSFTvs. Q1 2024SEC
Q1 2024May 13, 2024427$2.25BCORTCNQPXDvs. Q4 2023SEC
Q4 2023Jan 29, 2024424$2.20BCORTPXDCNQvs. Q3 2023SEC
Q3 2023Nov 2, 2023417$2.07BCORTPXDCNQvs. Q2 2023SEC
Q2 2023Jul 27, 2023415$2.07BCORTPXDAAPLvs. Q1 2023SEC
Q1 2023May 9, 2023411$1.94BCORTPXDCNQvs. Q4 2022SEC
Q4 2022Jan 31, 2023418$1.83BCORTPXDCNQvs. Q3 2022SEC
Q3 2022Oct 21, 2022410$1.78BCORTPXDCNQvs. Q2 2022SEC
Q2 2022Aug 11, 2022422$1.90BCORTPXDCNQvs. Q1 2022SEC
Q1 2022May 9, 2022436$2.22BCORTPXDCNQvs. Q4 2021SEC
Q4 2021Feb 11, 2022443$2.19BCORTPXDAAPLvs. Q3 2021SEC
Q3 2021Oct 27, 2021433$2.16BCORTPXDAAPLvs. Q2 2021SEC
Q2 2021Aug 3, 2021434$2.23BCORTPXDAAPLvs. Q1 2021SEC
Q1 2021Apr 21, 2021419$2.12BCORTPXDOMER–SEC

13D and 13G filings

Companies where Ingalls & Snyder LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

5 companies, largest stake first.

Companies where Ingalls & Snyder LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
STRSStratus Properties Inc13G/A13.60%1.09M shares+0.10 ppfrom 13.50%Feb 9, 20216 filingsApr 23, 2026SEC
DRRXDurect Corp13G/A8.50%2.68M shares–Mar 27, 20242 filingsFeb 21, 2025SEC
AERGApplied Energetics, Inc.13G7.70%17.2M shares−0.50 ppfrom 8.20%Feb 4, 20225 filingsApr 23, 2026SEC
CORTCorcept Therapeutics Inc13G/A6.80%7.26M shares−1.00 ppfrom 7.80%Feb 9, 20216 filingsApr 21, 2026SEC
HYFTMindWalk Holdings Corp.13G/A5.80%2.73M shares–Jul 7, 20233 filingsApr 23, 2026SEC

Latest filings

31 filings on file made by Ingalls & Snyder LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Ingalls & Snyder LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
STRSStratus Properties IncApr 23, 202610:13 AM ET13G/A13.60%1.09M shares+0.10 ppfrom 13.50%Dec 31, 2025SEC
OMEROmeros CorpApr 23, 202610:08 AM ET13G/A4.80%3.47M shares−2.40 ppfrom 7.20%Below 5%Dec 31, 2025SEC
HYFTMindWalk Holdings Corp.Apr 23, 202610:01 AM ET13G/A5.80%2.73M shares–Dec 31, 2025SEC
AERGApplied Energetics, Inc.Apr 23, 20269:50 AM ET13G7.70%17.2M shares−0.50 ppfrom 8.20%Dec 31, 2025SEC
CORTCorcept Therapeutics IncApr 21, 20264:20 PM ET13G/A6.80%7.26M shares−1.00 ppfrom 7.80%Dec 31, 2025SEC
OMEROmeros CorpFeb 21, 20255:42 PM ET13G/A7.20%4.16M shares–Dec 31, 2024SEC
DRRXDurect CorpFeb 21, 20255:37 PM ET13G/A8.50%2.68M shares–Dec 31, 2024SEC
CORTCorcept Therapeutics IncFeb 21, 20255:23 PM ET13G/A7.80%8.17M shares–Dec 31, 2024SEC
STRSStratus Properties IncFeb 21, 20253:41 PM ET13G/A13.50%1.09M shares–Dec 31, 2024SEC
AERGApplied Energetics, Inc.Feb 14, 20255:17 PM ET13G/A8.20%18.2M shares–Dec 31, 2024SEC
DRRXDurect CorpMar 27, 202413GOld format–New–SEC
STRSStratus Properties IncMar 27, 202413G/AOld format–––SEC
OMEROmeros CorpMar 27, 202413G/AOld format–––SEC
AERGApplied Energetics, Inc.Mar 27, 202413G/AOld format–––SEC
CORTCorcept Therapeutics IncMar 27, 202413G/AOld format–––SEC
HYFTMindWalk Holdings Corp.Feb 27, 202413GOld format–––SEC
HYFTMindWalk Holdings Corp.Jul 7, 202313DOld format–New–SEC
STRSStratus Properties IncFeb 17, 202313G/AOld format–––SEC
OMEROmeros CorpFeb 17, 202313G/AOld format–––SEC
CORTCorcept Therapeutics IncFeb 17, 202313G/AOld format–––SEC